Cargando…

MicroRNA调控肿瘤耐药的研究进展

Chemotherapy is one of the primary treatment for malignant tumors. Tumor multidrug resistance (MDR) is a major cause of clinical failure of chemotherapy; however the mechanisms of chemo-resistance have not been fully elucidated. Recently, microRNA is one of the new hotspots in life science. MicroRNA...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000396/
https://www.ncbi.nlm.nih.gov/pubmed/25342041
http://dx.doi.org/10.3779/j.issn.1009-3419.2014.10.06
_version_ 1783331710565351424
collection PubMed
description Chemotherapy is one of the primary treatment for malignant tumors. Tumor multidrug resistance (MDR) is a major cause of clinical failure of chemotherapy; however the mechanisms of chemo-resistance have not been fully elucidated. Recently, microRNA is one of the new hotspots in life science. MicroRNA regulates the expression of genes and plays roles a series of life events by post-transcriptional regulations, including cell proliferation, apoptosis, fat metabolism, nervous development, hormone secretion, tumor vessels generation, stem cell differentiation, tumor cell invasion and metastasis, and other physiological and pathological processes. Recent studies show that microRNA regulates the expression of multiple genes with high efficiency and specificity. The abnormal regulation of target genes by microRNA is responsible for tumor chemo-resistance, this may be an important component of the complexity of the regulation of chemo-resistance. Therefore, the study of microRNA and tumor drug resistance has profound practical significance. In this review, recent studies of tumor drug resistance, regulation of tumor drug resistance by microRNA, and microRNA as a potential target for tumor drug resistance therapy are reviewed.
format Online
Article
Text
id pubmed-6000396
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-60003962018-07-06 MicroRNA调控肿瘤耐药的研究进展 Zhongguo Fei Ai Za Zhi 综述 Chemotherapy is one of the primary treatment for malignant tumors. Tumor multidrug resistance (MDR) is a major cause of clinical failure of chemotherapy; however the mechanisms of chemo-resistance have not been fully elucidated. Recently, microRNA is one of the new hotspots in life science. MicroRNA regulates the expression of genes and plays roles a series of life events by post-transcriptional regulations, including cell proliferation, apoptosis, fat metabolism, nervous development, hormone secretion, tumor vessels generation, stem cell differentiation, tumor cell invasion and metastasis, and other physiological and pathological processes. Recent studies show that microRNA regulates the expression of multiple genes with high efficiency and specificity. The abnormal regulation of target genes by microRNA is responsible for tumor chemo-resistance, this may be an important component of the complexity of the regulation of chemo-resistance. Therefore, the study of microRNA and tumor drug resistance has profound practical significance. In this review, recent studies of tumor drug resistance, regulation of tumor drug resistance by microRNA, and microRNA as a potential target for tumor drug resistance therapy are reviewed. 中国肺癌杂志编辑部 2014-10-20 /pmc/articles/PMC6000396/ /pubmed/25342041 http://dx.doi.org/10.3779/j.issn.1009-3419.2014.10.06 Text en 版权所有©《中国肺癌杂志》编辑部2014 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle 综述
MicroRNA调控肿瘤耐药的研究进展
title MicroRNA调控肿瘤耐药的研究进展
title_full MicroRNA调控肿瘤耐药的研究进展
title_fullStr MicroRNA调控肿瘤耐药的研究进展
title_full_unstemmed MicroRNA调控肿瘤耐药的研究进展
title_short MicroRNA调控肿瘤耐药的研究进展
title_sort microrna调控肿瘤耐药的研究进展
topic 综述
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000396/
https://www.ncbi.nlm.nih.gov/pubmed/25342041
http://dx.doi.org/10.3779/j.issn.1009-3419.2014.10.06